aap: Successful start in 2015 with 45% LOQTEQ® sales increase and 23% growth in biomaterials business
aap Implantate AG (XETRA: AAQ.DE) made a successful start to financial year 2015 with significant sales growth. Accordin…
aap Implantate AG (XETRA: AAQ.DE) made a successful start to financial year 2015 with significant sales growth. Accordin…
aap realized in the second quarter of 2014 sales of EUR 8.1 million (previous year: continued business operations EUR 6.…
aap Implantate AG (XETRA: AAQ.DE) generated, according to preliminary figures, sales of EUR 8.0 million in the second qu…
aap gives notice that its subsidiary aap Biomaterials GmbH signed a supply agreement for a PMMA bone cement with a leadi…
In the first three months of the financial year 2014, aap sales totalled EUR 7.1 million (previous year: EUR 10.4 millio…
aap Implantate AG (XETRA: AAQ.DE), delivered on its financial and strategic goals, setting the stage for long term growt…
aap Implantate AG (XETRA: AAQ.DE) announced earlier today a definitive agreement under which a Private Equity Company wi…
aap Implantate AG (XETRA: AAQ.DE) announced today a definitive agreement under which a Private Equity Company will acqui…
aap Implantate AG (XETRA: AAQ.DE) increased its total sales by 3 % to EUR 28.4 million (previous year: EUR 27.5 million)…
aap Implantate AG (XETRA: AAQ.DE) achieved sales growth to EUR 19.6 million in the first half of 2013 (previous year: EU…